Inovatia Laboratories

Inovatia Laboratories

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14M

Overview

Founded in 2014 and headquartered in Fayette, Missouri (with a listed city of Salt Lake City potentially being an office or historical location), Inovatia Laboratories operates as a service-focused CRO in the diagnostics and proteomics sectors. Its business model is built on providing contract research and analytical testing services, positioning it as 'Revenue Generating' through client-funded projects and competitive grants like SBIR. The company's core activities include applied research, environmental monitoring (e.g., storm water), and developing proprietary technologies, though it does not have a traditional therapeutic pipeline.

DiagnosticsProteomics

Technology Platform

Integrated analytical service platform utilizing GC/MS, HPLC, ICP/MS, LC/MS/MS, NMR, FTIR, SEM/TEM, XRF, and other instrumentation for research, testing, deformulation, and method development.

Funding History

2
Total raised:$14M
Series A$12M
Seed$2M

Opportunities

Growing demand for outsourced analytical services in pharma, diagnostics, and environmental monitoring provides a stable market.
Success in SBIR grants offers non-dilutive funding to develop proprietary technologies that could be licensed or commercialized, creating additional revenue streams.

Risk Factors

Revenue is dependent on client projects and grant funding, leading to potential volatility.
The company faces significant competition from larger CROs and specialized labs, and its success is highly reliant on retaining key scientific personnel.

Competitive Landscape

Inovatia competes in a fragmented market with large global CROs (e.g., LabCorp, Charles River), specialized analytical labs, and university core facilities. Its differentiation lies in its broad instrumental suite, cross-industry expertise, and hands-on consultation model for complex problem-solving.